Author:
Rui Tao,Zhang Xiaobing,Guo Jufeng,Xiang Aizhai,Tang Ning,Liu Jian,Mao Zonglei
Abstract
Background: Serum exosomes are emerging as key liquid biopsy biomarkers for the early diagnosis of cancer. However, the proportion and distribution of small RNA (sRNA) species from serum exosomes of hepatocellular carcinoma (HCC) patients remain unclear. Effective and reliable biomarkers for HCC diagnosis should be explored. Methods: In this study, we aimed to use sRNA sequencing to profile the sRNAs of serum exosomes in HCC and non-tumor donors. The serum exosomes of 124 HCC patients and 46 non-tumor donors were enrolled for detecting the values of the potential biomarkers for the diagnosis of HCC. Results: We found that miRNAs accounted for the maximal percentage of all types of sRNAs both in the serum exosomes of HCC patients and non-tumor donors. This indicated that the serum-exosome-derived microRNAs (miRNAs) were the most valuable as potential biomarkers in HCC diagnosis. Then, miRNAs were set as research candidates. In our Chinese cohorts, three serum-exosome-derived miRNAs (miR-122-5p, let-7d-5p, and miR-425-5p) could be promising biomarkers for distinguishing HCC patients from non-tumor donors. In addition, they were preferred for the early diagnosis of HCC. We also presented the base distribution of some novel serum-exosome-derived miRNAs and described the potential values as biomarkers. Conclusions: The results suggested that the serum-exosome-derived miRNAs were the most crucial sRNA species and they highlighted the potential of serum-exosome-derived miRNAs as promising biomarkers for HCC diagnosis.
Funder
Zhejiang Provincial Natural Science Foundation of China
Medical Health Science and Technology Project of Zhejiang Provincial Health Commission, China
Reference45 articles.
1. Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis;Gupta;Ann. Intern. Med.,2003
2. Exosomes: The Indispensable Messenger in Tumor Pathogenesis and the Rising Star in Antitumor Applications;Wang;Adv. Biosyst.,2019
3. Słomka, A., Kornek, M., and Cho, W.C. (2022). Small Extracellular Vesicles and Their Involvement in Cancer Resistance: An Up-to-Date Review. Cells, 11.
4. Multiplexed Profiling of Extracellular Vesicles for Biomarker Development;Jiang;Nano-Micro Lett.,2021
5. Cancer diagnosis: From tumor to liquid biopsy and beyond;Vaidyanathan;Lab Chip,2018
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献